It said that the risk of DTV (deep vein thrombosis) is greatest for men undergoing hormone therapy for the disease and in younger men with advanced-stage cancer.

This large study in 76,000 Swedish men looked at the rates of thromboembolic diseases, which include DVT and pulmonary embolism (PE), and found that they occurred more often in men with prostate cancer than in the general population. The risk of these diseases varied according to which cancer treatment was used, with the highest risk in men who were primarily treated with hormone therapy. These men had about 2.5 times the rate of DVT and twice the rate of PE compared to the general male population. More …